LES to Honor 15th Annual Deals of Distinction™ Award Winners at its Phoenix Annual Meeting, October 21-23
LES Members to Be Recognized for Outstanding Achievements in the Field of Licensing Business Deals at LES 2019 Annual Meeting in Phoenix, October 21
RESTON, VA. – Sept. 30, 2019 — The Licensing Executives Society (U.S.A and Canada), Inc. (LES) today announced the recipients of its Deals of Distinction™ Awards in four industry sectors. The annual program, now in its fifteenth year, recognizes the LES member companies that orchestrated the year’s most outstanding licensing and business deals in each sector. The awards will be presented during the LES Annual Meeting Award Luncheon, Monday, October 21, 2019, at the Phoenix JW Marriott Desert Ridge Resort & Spa. Several key dealmakers will be on hand to provide insights on their winning deals.
” Through well-organized commercialization of intellectual property, we can drive growth across all business sectors in our global economy, from traditional business products to emerging product technologies. The 2019 award winners demonstrate exciting and impactful innovations within the licensing industry, and we are pleased to recognize their success,” said LES President and Chair Bob Held. “At our Annual Meeting in Phoenix, we’ll celebrate these deals in a variety of ways, as well as hearing from our members and the dealmakers themselves, about the key aspects of those deals. Our thanks go to the Awards Committee for highlighting the continued achievements of LES members.”
This year’s Deals of Distinction™ Award recipients include:
- Chemicals, Energy, Environment & Materials Sector: Massachusetts Institute of Technology and Commonwealth Fusion Systems — MIT and Commonwealth Fusion Systems launch novel approach to fusion power
- High Technology Sector: Sisvel International S.A. and RPX Corporation — “Aggregator meets Aggregator”: Sisvel and RPX ink major Wi-Fi SEP licensing deal
- Industry-University-Government Interface Sector: Oregon Health & Science University and the University of Pittsburgh; Ultragenyx Pharmaceutical Inc. — Rare pediatric disease dataset license
- Life Sciences Sector: Dicerna Pharmaceuticals and Eli Lilly and Company – Global licensing and research collaboration focused on the discovery, development and commercialization of RNAi therapies in cardio-metabolic disease, neurodegeneration and pain.
All LES members attending the Annual Meeting are invited to the Award Luncheon. Additional information about the October 20-23 LES Annual Meeting, including registration instructions, can be found at https://lesmeetings.org/. Previous honorees and their award-winning deals are listed at www.lesusacanada.org/?dda.
About Licensing Executives Society (U.S.A. and Canada), Inc.
Established in 1965, Licensing Executives Society (U.S.A. and Canada), Inc. (LES) is a professional society of 2,500 members engaged in the creation, commercial development and orderly transfer of intellectual property rights; protection and management of intellectual capital; and intellectual capital management standards development. LES members are accountants, business leaders, business model innovators, consultants, deal-makers, economists, engineers, IP valuation experts, lawyers, licensing executives, lobbyists, merger and acquisition experts, public policy leaders, scientists, strategic planners, supply chain managers, tax specialists and technology transfer specialists. These members represent innovation-centered enterprises of all sizes and kinds — such as government laboratories, professional services firms, universities, operating companies, regulatory authorities, licensing specialty firms and trade associations. LES is a member society of the Licensing Executives Society International, Inc. (LESI), which has 32 sister societies representing 8,000 members in 90 countries. For more information about LES, go to www.lesusacanada.org.